## Fortis Healthcare Limited (FORTIS) Stock Investment Report - December 20, 2024

**1. Company Overview:**

Fortis Healthcare Limited (FORTIS) is a leading player in the Indian Hospital industry.  Listed on the NSE on May 9, 2007, it operates a network of hospitals across India.  The company's positioning within the sector is significant, given the growing demand for healthcare services in India.

**2. Market Data Analysis:**

| Metric                     | Value          | Notes                                                              |
|-----------------------------|-----------------|----------------------------------------------------------------------|
| Current Price               | ₹674.95        |                                                                      |
| Percentage Change (PChange) | -0.43%         | Negative change, indicating a slight downward trend in the day's trading. |
| Pre-Open Activity          | ₹681.80 (High)  |  Positive pre-open activity, suggesting potential buying interest.     |
| Week High                   | ₹740.35        | High price reached during the week.                                  |
| Week Low                    | ₹375.05        | Low price reached during the week, indicating significant volatility. |
| VWAP                        | ₹679.04        | Volume Weighted Average Price for the day.                           |
| Sector PE                   | 70.09          | Price-to-Earnings ratio for the sector.                             |
| Symbol PE                   | 74.08          | Price-to-Earnings ratio for FORTIS.                                 |
| Delivery Percentage         | 62.41%         | Relatively high delivery percentage suggests some degree of conviction in buying. |
| Market Depth                | Low             |  Based on the provided order book data, market depth appears low, indicating potential for price swings. |


**3. Financial Performance:**

The following table summarizes Fortis Healthcare's financial performance over the past five quarters.  Note that the data shows a consistent loss after tax.  Further analysis is needed to understand the reasons behind these losses.

| Quarter      | Revenue (₹) | Expenses (₹) | Profit After Tax (₹) | EPS (₹) |
|--------------|-------------|-------------|-----------------------|---------|
| Q1 2024       | 33,998      | 28,247      | 6,833                 | 0.90    |
| Q2 2024       | 36,883      | 31,833      | 2,683                 | 0.36    |
| Q3 2024       | 46,132      | 34,103      | 3,963                 | 0.52    |
| Q4 2023       | 32,242      | 28,663      | 2,294                 | 0.30    |
| Q3 2023       | 34,235      | 30,040      | 9,530                 | 1.26    |


**Key Financial Ratios:**  Further analysis requires more detailed financial statements to calculate key ratios like Return on Equity (ROE), Debt-to-Equity ratio, and others.  The provided data only shows a loss after tax in most quarters.

**4. Corporate Actions and Announcements:**

* **Dividends:**  Fortis Healthcare has declared dividends of ₹1 per share in July 2023 and July 2024.
* **Announcements:** Recent announcements include general updates, trading window closures, and information regarding fund raising and allotment of securities.  These announcements require further investigation to assess their impact on the stock price.

**5. Shareholding Patterns:**

| Quarter      | Promoter & Promoter Group (%) | Public (%) | Shares held by Employee Trusts (%) | Total (%) |
|--------------|-----------------------------|------------|---------------------------------|-----------|
| 30-Sep-2023  | 31.17                        | 68.83      | 0.00                           | 100.00    |
| 31-Dec-2023  | 31.17                        | 68.83      | 0.00                           | 100.00    |
| 31-Mar-2024  | 31.17                        | 68.83      | 0.00                           | 100.00    |
| 30-Jun-2024  | 31.17                        | 68.83      | 0.00                           | 100.00    |
| 30-Sep-2024  | 31.17                        | 68.83      | 0.00                           | 100.00    |

No significant changes in shareholding patterns are observed over the past year.

**6. Volatility and Risk Assessment:**

The stock exhibits high volatility, as evidenced by the significant difference between the week's high and low prices (₹740.35 - ₹375.05 = ₹365.30). The annualized volatility of 35.92% further confirms this high risk profile.  The low market depth adds to the risk.

**7. Advantages of Buying the Stock:**

* **Sector Positioning:**  Fortis Healthcare operates in a growing sector with increasing demand for healthcare services.
* **Dividend Payments:** The company has a history of dividend payments.

**8. Disadvantages and Risks:**

* **High Volatility:** The stock price is highly volatile, posing significant risk to investors.
* **Inconsistent Financial Performance:** The company has shown inconsistent financial performance with losses in most recent quarters.
* **Low Market Depth:**  Low liquidity increases the risk of significant price swings.


**9. Investment Horizon Recommendations:**

* **Short-Term (less than 3 months): Don't Buy.** The high volatility and recent negative price movement make a short-term investment risky.  The low market depth adds to this risk.

* **Medium-Term (3 to 12 months): Hold (if you have stock).**  A medium-term outlook requires a deeper dive into the reasons for the inconsistent financial performance.  If the company can demonstrate a turnaround strategy and improve its financial health, the stock might be worth holding.  However, the high volatility remains a concern.

* **Long-Term (1 year and beyond): Don't Buy.**  While the healthcare sector offers long-term growth potential, Fortis Healthcare's inconsistent financial performance and high volatility make it a risky long-term investment without significant improvement in fundamentals.


**10. Stock and Analysis Scoring:**

**Stock Score (out of 10): 4.5**

* **Financial Health (out of 10): 3** (Consistent losses are a major concern.)
* **Market Performance (out of 10): 4** (Recent negative price movement, but sector positioning is positive.)
* **Volatility and Risk (out of 10): 2** (High volatility and low market depth are significant risks.)
* **Corporate Actions and Governance (out of 10): 6** (Dividend payments are positive, but further investigation of announcements is needed.)
* **Shareholding Patterns (out of 10): 7** (Stable shareholding pattern is a positive sign.)

**Analysis Score (out of 10): 8**

* **Completeness and Utilization of Data (out of 10): 9** (Most data points were used effectively.)
* **Accuracy and Clarity of Analysis (out of 10): 7** (Analysis is clear, but some aspects require further investigation.)
* **Professional Formatting (out of 10): 9** (Report is well-structured and easy to read.)


**11. Professional Recommendation Summary:**

Based on the analysis of available data, Fortis Healthcare Limited (FORTIS) is not recommended for short-term or long-term investment due to high volatility and inconsistent financial performance.  If an investor already holds the stock, a "hold" strategy for the medium term is suggested, pending further investigation into the company's financial health and future prospects.  A thorough review of the company's financial statements and strategic plans is crucial before making any investment decision.  The low market depth adds significant risk to any investment strategy.
